Ivermectin is an antiparasitic medicine known for its effectiveness in treating parasitic infections. Doctors often recommend it for treating infections caused by worms and parasites. In recent years, the medicine has drawn attention for its potential in cancer treatment. This has led people to think and question whether the medicine can be used for cancer treatment.
Recent studies show that several cancer patients responded positively to this drug when prescribed by doctors. Nevertheless, studies are underway to assess the potential impact of the medicine on cancer cells. It is always important to understand what science has to say before concluding.
Potential Mechanisms of Action Against Cancer
In preclinical studies using petri dishes and animal models, Ivermectin inhibits the growth and proliferation of human cancer cells.
Here is an emphasis on the role that Ivermectin may play in cancer treatment based on current scientific studies:
- Induction of Cell Death (Apoptosis and Autophagy): Ivermectin triggers cell death by generating high levels of reactive oxygen species and causing mitochondrial damage, which leads to apoptosis and non-survival autophagy.
- Inhibition of Proliferation and Metastasis: It targets and suppresses PAK1, a protein involved in tumor development and metastasis across various cancer types.
- Inhibition of Cancer Stem Cells (CSCs): In various types of cancer, such as breast cancer, it targets cell populations that are enriched in CSCs.
- Reversal of Multi-Drug Resistance (MDR): There is evidence that Ivermectin suppresses P-glycoprotein, which is responsible for removing chemotherapy agents from cancer cells.
- Modulation of the Tumor Microenvironment: Ivermectin has been shown to “turn cold tumors hot” by inducing immunogenic cell death.
Types of Cancers Showing Potential Response
Pre-clinical research (in vitro and in vivo) results show potential for the treatment of a variety of cancers, including:
- Breast Cancer: Especially Triple Negative Breast Cancer (TNBC).
- Cancers of the Digestive System: Gastric Cancer, Colorectal Cancer.
- Cancers of the Urinary System: Renal Cell Carcinoma, Bladder Cancer.
- Hematopoietic Cancers: Leukemia.
What Do Current Studies Say?
Some studies suggest that it has anti-cancer properties as well. It might help stop cancer cell growth or induce cancer cell death.
- Preclinical (Promising): Research indicates that ivermectin is effective in killing cancer cells in a laboratory setting, with over 50% reduction in tumor volume in mice. Hundreds of studies support the use of ivermectin in cancer treatment.
- Clinical (Extremely Limited): Currently, there is no evidence from large-scale, real-world randomized controlled trials (RCTs) that it works.
- Active Investigations: The United States’ National Cancer Institute (NCI) is conducting preclinical research and early-phase (Phase 1/2) human trials of immunotherapy for metastatic triple-negative breast cancer.
Can Ivermectin Replace Cancer Treatment?
No, Ivermectin cannot replace existing cancer treatments. Existing treatments for cancer, such as chemotherapy, radiation, and targeted therapies, are well supported by evidence. These treatments are specifically intended for cancer treatment. These treatments are effective and safe. Using Ivermectin instead of proper treatment for cancer can be dangerous, as it may worsen the condition. Cancer needs proper and accurate treatment. However, patients can take Ivermectin under medical supervision. Medications like Iverheal tablets are becoming popular in treating human cancer.
Future of Ivermectin in Cancer Research
Ongoing research is examining the effects of Ivermectin in the treatment of cancer. Scientists are trying to find out how it may affect cancer cells. In the future, there may be clearer answers about it. However, it is still too early to consider it a reliable treatment.
In the future, if there are trials of Ivermectin, they may yield positive results and play a different role. However, until then, it is still an idea. Medical decisions are based on evidence. Doctors must guide patients regarding the usage of this medication to treat cancer.
Conclusion
Ivermectin is not a cancer drug and is not used to treat cancer. Though some initial results look promising, there is no concrete evidence that it really works in real patients. People must not use Ivermectin without a doctor’s advice.
Cancer treatment involves proper diagnosis and proper guidance. It is important to use proven methods for treating cancer. It is important to consult a doctor before using any new and experimental methods.